[144] SPECIAL OPPORTUNITIES FUND, INC. SEC Filing
SPE reported a planned sale of common stock by an existing holder under Rule 144. The notice covers 912 shares of common stock with an aggregate market value of $22,617.60, to be sold through Fidelity Brokerage Services LLC on or about 11/21/2025 on the NYSE. Shares outstanding were 2,235,775 as context.
The seller reports earlier acquisitions of preferred securities via open market purchases in January 2022, including amounts of 364 and 548 units paid in cash or check. The filing also lists recent sales over the past three months from the Special Opportunities Fund, including a transaction of 53,541 units for gross proceeds of $1,338,525.00.
- None.
- None.
FAQ
What does the Form 144 filing for SPE disclose?
The Form 144 discloses that an existing holder intends to sell 912 shares of SPE common stock with an aggregate market value of $22,617.60 through Fidelity Brokerage Services LLC on or about 11/21/2025 on the NYSE.
How many SPE shares are outstanding in this Form 144 notice?
The notice states that the number of shares or other units outstanding is 2,235,775, providing a baseline for the issuer’s common equity.
What prior securities sales related to SPE are reported in the last 3 months?
The filing lists sales by Kovitz Investment Group Par Special Opportunities Fund, including transactions such as 53,541 units sold on 09/12/2025 for gross proceeds of $1,338,525.00, along with several smaller sales.
How were the securities in the SPE Form 144 originally acquired?
The notice shows preferred securities acquired via open market purchases on 01/24/2022 and 01/26/2022, in amounts of 364 and 548 units, with payment made by cash/check.
Which broker is handling the planned SPE share sale under Rule 144?
The planned sale of 912 SPE common shares is to be executed through Fidelity Brokerage Services LLC, located at 245 Summer Street, Boston, MA 02110.
What representation does the selling holder make in the SPE Form 144?
The selling holder represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as required under the Form 144 notice.